Darin Zehrung

Darin Zehrung has over 25 years of experience in global public health, medical device and combination product development, country-based research, strategic analysis, program building and business development & fundraising.

He managed staff based globally advancing health innovations as Global Program Leader for the Medical Devices and Health Technologies (MDHT) program at PATH, overseeing the areas of vaccine and pharmaceutical packaging, delivery, and formulation technologies, supply chain innovations, as well as reproductive health, maternal and neonatal health, respiratory support, and safe water technologies. He has worked in close collaboration with innovation developers in the private and public sectors to improve global public health.

A significant focus of his efforts has been in the immunization and drug delivery space, be it advancing innovations such as injection safety technologies (auto-disable syringe, prefilled injection systems, needle-free technologies such as microarray patches, etc.) or supporting the development of vaccines and drugs. Prior to and during his time as MDHT program leader at PATH, he was also a member of the leadership team for the Center for Vaccine Innovation and Access, working closely with disease and functional area leaders and teams to co-create new projects, navigate vaccine drug substance and product requirements as well as research challenges. He has worked closely with global level stakeholders during his public health career, focused on strengthening health systems through the introduction and use of a variety of technologies to improve health outcomes and enable greater equity in healthcare access globally. After his career at PATH, he was the Chief Business Development Officer for a needle-free drug delivery technology company, advancing product use for polio eradication efforts.

In 2023 he founded Zehrung Global Health LLC and has been consulting with private and public sector technology developers and manufacturers, to include working with the World Health Organization on measles-rubella microarray patch (MR-MAP) technology.

Darin has presented at numerous conferences, advisory committees, and technical meetings, and has published more than 38 peer-reviewed journal articles and book chapters. Darin is a United States Army veteran and has a Bachelor of Science in human biology and a Master of Business Administration from Western Washington University.